Drug Information

General Information
Drug ID
DR00280
Drug Name
Nicardipine
Synonyms
2-(Benzylmethylamino)ethylmethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Cardene (TN); Cardene IV; Methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nicardipine (INN); Nicardipine LA; Nicardipine [INN:BAN]; Nicardipino; Nicardipino [INN-Spanish]; Nicardipinum; Nicardipinum [INN-Latin]; Y-93
Drug Type
Small molecular drug
Indication Angina [ICD11: BA40] Approved [1]
High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C26H29N3O6
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
InChI
InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3
InChIKey
ZBBHBTPTTSWHBA-UHFFFAOYSA-N
CAS Number
CAS 55985-32-5
Pharmaceutical Properties Molecular Weight 479.5 Topological Polar Surface Area 114
Heavy Atom Count 35 Rotatable Bond Count 10
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 8
XLogP
3.8
PubChem CID
4474
PubChem SID
11119969 , 11120457 , 11120945 , 11121454 , 11121934 , 11147052 , 11335715 , 11360954 , 11362523 , 11364266 , 11365085 , 11366828 , 11367647 , 11369390 , 11370317 , 11370318 , 11372542 , 11373248 , 11373883 , 11375809 , 11377552 , 11461926 , 11466411 , 11467531 , 11485226 , 11486222 , 11489231 , 11491267 , 11492237 , 11495186 , 14907905 , 26755701 , 26755702 , 29223569 , 46504482 , 47216524 , 47216525 , 47515065 , 47588738 , 47810485 , 47810486 , 47810487 , 47810488 , 48034827 , 48184723 , 6300545 , 7578094 , 7980119 , 8152757 , 9473
ChEBI ID
ChEBI:7550
TTD Drug ID
D0T0KA
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data P-GP Transporter Info Km = 2.6 microM Spodoptera frugiperda (Sf9) cells-MDR1 [3]
References
1 Nicardipine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
3 Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J. 2007 Jan 15;401(2):597-605.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.